Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.28 | N/A |
| PEG Ratio (TTM) | -1.32 | N/A |
| P/S Ratio (TTM) | 1.17 | N/A |
| P/B Ratio (TTM) | 2.04 | N/A |
| P/FCF Ratio (TTM) | 160.86 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.73 | N/A |
| Price to 5YR AVG FCF Ratio | 9.22 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.70% | N/A |
| ROE (TTM) | 6.89% | N/A |
| Net Profit Margin (TTM) | 4.03% | N/A |
| ROIC 5YR AVG | 30.18% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 478.60% | 71.06% | 48.48% |
| Revenue | 2.09% | 7.62% | 7.11% |
| Net Income | 476.84% | 73.90% | 49.89% |
| Cash Flow | 64.74% | 30.78% | 10.85% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.42 | N/A |
| Quick Ratio (TTM) | 0.42 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 7.40 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.61 | N/A |
| LTL to 5YR AVG FCF | 0.51 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.54% | N/A |